# A Phase 2 Trial for Men With Metastatic Prostatic Adenocarcinoma

> **NCT04090775** · PHASE2 · COMPLETED · sponsor: **Rampart Health, L.L.C.** · enrollment: 12 (actual)

## Conditions studied

- Metastatic Prostatic Adenocarcinoma

## Interventions

- **DRUG:** Opdivo Injectable Product
- **DRUG:** Yervoy Injectable Product
- **DRUG:** Cytoxan
- **PROCEDURE:** Cryosurgical freezing (cryosurgery)

## Key facts

- **NCT ID:** NCT04090775
- **Lead sponsor:** Rampart Health, L.L.C.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-28
- **Primary completion:** 2020-07-30
- **Final completion:** 2022-01-31
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2022-06-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04090775

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04090775, "A Phase 2 Trial for Men With Metastatic Prostatic Adenocarcinoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04090775. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*